Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$488.1K
32.87K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 32.87K shares of AVALO THERAPEUTICS, INC. valued at approximately $488.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/29/2026ACC: 0001950047-26-003835
Officer· Interim CFO
Since Apr 2020
32.87K
Shares to sell
$488.1K
Approx. market value
16.91K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/28/2025
16.91KTotal acquired16.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/28/2025 | Restricted Stock Units N/A | 16.91K | — |
| Total | 16.91K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.98K
Market value
$136.8K
4/2/2026
—Completed
Units to sell
7.98K
Market value
$133.8K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.91K
Market value
$217.5K
4/29/2026
Total
Units
32.87K
Value
$488.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2026 | 7.98K | $136.8K | — | Completed |
4/1/2026 | 7.98K | $133.8K | — | Completed |
| Planned — Approximate Date | ||||
4/29/2026 | 16.91K | $217.5K | NASDAQ | Planned |
| Total | 32.87K | $488.1K | ||